Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 2
1968 1
1969 2
1970 1
1971 2
1972 3
1973 2
1974 1
1975 5
1976 3
1977 1
1979 2
1980 1
1981 3
1982 1
1983 2
1985 1
1986 1
1987 2
1989 3
1990 2
1991 2
1992 1
1993 2
1994 3
1995 7
1996 5
1997 5
1998 2
1999 4
2000 8
2001 14
2002 13
2003 9
2004 12
2005 7
2006 12
2007 19
2008 21
2009 21
2010 23
2011 21
2012 15
2013 27
2014 36
2015 41
2016 34
2017 29
2018 41
2019 46
2020 44
2021 51
2022 45
2023 36
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

626 results

Results by year

Filters applied: Full text. Clear all
Page 1
Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial.
Shing JZ, Hu S, Herrero R, Hildesheim A, Porras C, Sampson JN, Schussler J, Schiller JT, Lowy DR, Sierra MS, Carvajal L, Kreimer AR; Costa Rica HPV Vaccine Trial Group. Shing JZ, et al. Lancet Oncol. 2022 Jul;23(7):940-949. doi: 10.1016/S1470-2045(22)00291-1. Epub 2022 Jun 13. Lancet Oncol. 2022. PMID: 35709811 Free PMC article. Clinical Trial.
We aimed to evaluate HPV vaccine efficacy against cervical intraepithelial neoplasia grade 2 or worse (CIN2+) and cervical intraepithelial neoplasia grade 3 or worse (CIN3+) attributed to non-preventable HPV types in the long-term follow-up phase of the Costa Rica H …
We aimed to evaluate HPV vaccine efficacy against cervical intraepithelial neoplasia grade 2 or worse (CIN2+) and cervical intraepithelial n …
Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.
Porras C, Tsang SH, Herrero R, Guillén D, Darragh TM, Stoler MH, Hildesheim A, Wagner S, Boland J, Lowy DR, Schiller JT, Schiffman M, Schussler J, Gail MH, Quint W, Ocampo R, Morales J, Rodríguez AC, Hu S, Sampson JN, Kreimer AR; Costa Rica Vaccine Trial Group. Porras C, et al. Lancet Oncol. 2020 Dec;21(12):1643-1652. doi: 10.1016/S1470-2045(20)30524-6. Lancet Oncol. 2020. PMID: 33271093 Free PMC article. Clinical Trial.
METHODS: Women aged 18-25 years were enrolled in a randomised, double-blind, controlled trial in Costa Rica, between June 28, 2004, and Dec 21, 2005, designed to assess the efficacy of a bivalent vaccine for the prevention of infection with HPV 16/18 and associated …
METHODS: Women aged 18-25 years were enrolled in a randomised, double-blind, controlled trial in Costa Rica, between June 28, …
The clinical diagnosis and management of urinary tract infections in children and adolescents.
Korbel L, Howell M, Spencer JD. Korbel L, et al. Paediatr Int Child Health. 2017 Nov;37(4):273-279. doi: 10.1080/20469047.2017.1382046. Epub 2017 Oct 5. Paediatr Int Child Health. 2017. PMID: 28978286 Review.
In this manuscript, we review the diagnosis and management of acute and recurrent UTI in the paediatric and adolescent populations....
In this manuscript, we review the diagnosis and management of acute and recurrent UTI in the paediatric and adolescent populations... …
Cervicovaginal microbiome and natural history of HPV in a longitudinal study.
Usyk M, Zolnik CP, Castle PE, Porras C, Herrero R, Gradissimo A, Gonzalez P, Safaeian M, Schiffman M, Burk RD; Costa Rica HPV Vaccine Trial (CVT) Group. Usyk M, et al. PLoS Pathog. 2020 Mar 26;16(3):e1008376. doi: 10.1371/journal.ppat.1008376. eCollection 2020 Mar. PLoS Pathog. 2020. PMID: 32214382 Free PMC article. Clinical Trial.
METHODS: This study was nested within the placebo arm of the Costa Rica HPV Vaccine Trial that included women aged 18-25 years of age. ...
METHODS: This study was nested within the placebo arm of the Costa Rica HPV Vaccine Trial that included women aged 18-25 years …
Montelukast in paediatric asthma and allergic rhinitis: a systematic review and meta-analysis.
Mayoral K, Lizano-Barrantes C, Zamora V, Pont A, Miret C, Barrufet C, Caballero-Rabasco MA, Praena-Crespo M, Bercedo A, Valdesoiro-Navarrete L, Guerra MT, Pardo Y, Martínez Zapata MJ, Garin O, Ferrer M; ARCA Group. Mayoral K, et al. Eur Respir Rev. 2023 Oct 18;32(170):230124. doi: 10.1183/16000617.0124-2023. Print 2023 Dec 31. Eur Respir Rev. 2023. PMID: 37852659 Free PMC article. Review.
CONCLUSIONS: The synthesis of the available evidence suggests that, in children and adolescents, montelukast was effective in controlling asthma symptoms when compared with placebo, but inhaled corticosteroids were superior in controlling symptoms, especially at night-time …
CONCLUSIONS: The synthesis of the available evidence suggests that, in children and adolescents, montelukast was effective in control …
Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial.
Kreimer AR, Sampson JN, Porras C, Schiller JT, Kemp T, Herrero R, Wagner S, Boland J, Schussler J, Lowy DR, Chanock S, Roberson D, Sierra MS, Tsang SH, Schiffman M, Rodriguez AC, Cortes B, Gail MH, Hildesheim A, Gonzalez P, Pinto LA; Costa Rica HPV Vaccine Trial (CVT) Group. Kreimer AR, et al. J Natl Cancer Inst. 2020 Oct 1;112(10):1038-1046. doi: 10.1093/jnci/djaa011. J Natl Cancer Inst. 2020. PMID: 32091594 Free PMC article. Clinical Trial.
METHODS: HPV infections were compared between HPV16 or 18-vaccinated women aged 18 to 25 years who received one (N = 112), two (N = 62), or three (N = 1365) doses, and age- and geography-matched unvaccinated women (N = 1783) in the long-term follow-up of the Costa Rica …
METHODS: HPV infections were compared between HPV16 or 18-vaccinated women aged 18 to 25 years who received one (N = 112), two (N = 62), or …
Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination.
Avila-Aguero ML, Ulloa-Gutierrez R, Camacho-Badilla K, Soriano-Fallas A, Arroba-Tijerino R, Morice-Trejos A. Avila-Aguero ML, et al. Expert Rev Vaccines. 2017 Mar;16(3):229-234. doi: 10.1080/14760584.2017.1247700. Epub 2016 Oct 27. Expert Rev Vaccines. 2017. PMID: 27786560 Review.
To describe the impact following a 1-dose Varicella vaccination schedule introduced in Costa Rica in September 2007. Areas covered: This is a retrospective review using epidemiologic surveillance national databases of varicella cases and hospitalizations, period 200 …
To describe the impact following a 1-dose Varicella vaccination schedule introduced in Costa Rica in September 2007. Areas cov …
Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial.
Baisley K, Kemp TJ, Kreimer AR, Basu P, Changalucha J, Hildesheim A, Porras C, Whitworth H, Herrero R, Lacey CJ, Schiller JT, Lucas E, Mutani P, Dillner J, Indangasi J, Muwonge R, Hayes RJ, Pinto LA, Watson-Jones D. Baisley K, et al. Lancet Glob Health. 2022 Oct;10(10):e1485-e1493. doi: 10.1016/S2214-109X(22)00306-0. Lancet Glob Health. 2022. PMID: 36113532 Free PMC article. Clinical Trial.
We compared antibody responses after one dose of HPV vaccine in the Dose Reduction Immunobridging and Safety Study (DoRIS), a randomised trial of different HPV vaccine schedules in Tanzania, to those from two observational HPV vaccine trials that found high efficacy of one dose u …
We compared antibody responses after one dose of HPV vaccine in the Dose Reduction Immunobridging and Safety Study (DoRIS), a randomised tri …
Pediatric Ocular Toxocariasis in Costa Rica: 1998-2018 Experience.
Martinez J, Ivankovich-Escoto G, Wu L. Martinez J, et al. Ocul Immunol Inflamm. 2021 Nov 17;29(7-8):1246-1251. doi: 10.1080/09273948.2020.1792513. Epub 2020 Aug 18. Ocul Immunol Inflamm. 2021. PMID: 32809906
METHODS: Retrospective review of patients diagnosed with ocular toxocariasis at a pediatric referral center from 1998 until 2018 in Costa Rica. RESULTS: 157 patients were diagnosed with ocular toxocariasis with a mean follow-up of 3.1 years. ...CONCLUSIONS: Most pat …
METHODS: Retrospective review of patients diagnosed with ocular toxocariasis at a pediatric referral center from 1998 until 2018 in Costa …
626 results